What is the current annual SG&A of GSK?

As of today, GSK annual SG&A is $1.24B

What is 1-year change in GSK annual SG&A?

GSK annual SG&A is up +389.64% year-over-year

What is 3-year change in GSK annual SG&A?

GSK annual SG&A is up +423.81% over the past 3 years

How far is GSK annual SG&A from its all-time high?

GSK annual SG&A is currently -93.85% below its historical high of $20.15B set on December 31, 2010

How does GSK annual SG&A rank versus sector peers?

GSK annual SG&A is higher than 99.03% of companies in Healthcare sector

When is GSK next annual earnings release?

As of today, the next annual earnings release for GSK has not been scheduled

What is the current quarterly SG&A of GSK?

As of today, GSK quarterly SG&A is $2.96B

What is GSK quarterly SG&A most recent change?

GSK quarterly SG&A was up +3.52% on June 30, 2026

What is 1-year change in GSK quarterly SG&A?

GSK quarterly SG&A is up +3.40% year-over-year

How far is GSK quarterly SG&A from its all-time high?

GSK quarterly SG&A is currently -57.90% below its historical high of $7.02B set on December 31, 2010

How does GSK quarterly SG&A rank versus sector peers?

GSK quarterly SG&A is higher than 99.25% of companies in Healthcare sector

When is GSK next earnings release?

The next earnings release for GSK is on October 28, 2026

What is the current TTM SG&A of GSK?

As of today, GSK TTM SG&A is $57.71B

What is GSK TTM SG&A most recent change?

GSK TTM SG&A was up +5.79% on June 30, 2026

What is 1-year change in GSK TTM SG&A?

GSK TTM SG&A is up +317.68% year-over-year

How does GSK TTM SG&A rank versus sector peers?

GSK TTM SG&A is higher than 97.94% of companies in Healthcare sector

When is GSK next earnings release?

The next earnings release for GSK is on October 28, 2026

GSK Plc (GSK) SG&A History & Chart Since 1986

Annual SG&A

$1.24B$985.81M+389.64%

December 31, 2025

Summary

Current Value: As of today, GSK annual SG&A is $1.24B, up +389.64% on December 31, 2025
Historical Performance: GSK annual SG&A is up +423.81% over the past 3 years, up +136.78% over the past 5 years
All-Time High Comparison: GSK annual SG&A is currently -93.85% below its historical high of $20.15B set on December 31, 2010
3-Year Low Comparison: GSK annual SG&A is +423.81% above its 3-year low of $236.50M reached on an earlier date
Sector Comparison: GSK annual SG&A is higher than 99.03% of companies in Healthcare sector

SG&A Chart

beforeafter

Performance

GSK Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual SG&A	Dec 31, 25	$1.24B	+389.6%	+423.8%	+136.8%	-93.8%
Quarterly SG&A	Jun 30, 26	$2.96B	+3.4%	+4.1%	+25.1%	-22.7%
TTM SG&A	Jun 30, 26	$57.71B	+317.7%	+438.4%	+332.9%	+230.1%
Price	Aug 20, 26	$51.96	+29.7%	+50.7%	+21.8%	+24.9%
Annual Operating Expenses	Dec 31, 25	$21.78B	+5.0%	+38.4%	+13.7%	-10.1%
Annual Operating Profit	Dec 31, 25	$9.45B	+30.6%	+14.8%	-10.0%	+22.9%
Annual D&A	Dec 31, 25	$3.05B	-6.5%	+15.3%	+1.1%	+17.7%
Annual Revenue	Dec 31, 25	$43.05B	+7.4%	+19.2%	-1.5%	-1.8%

SG&A Highs

GSK Annual SG&A Highs Comparison
Period	High	Date	Current
3Y	$1.24B	Dec 31, 25	at high
5Y	$1.24B	Dec 31, 25	at high
All	$20.15B	Dec 31, 10	-93.8%

SG&A Lows

GSK Annual SG&A Lows Comparison
Period	Low	Date	Current
3Y	$236.50M	N/A	+423.8%
5Y	$232.43M	Dec 31, 21	+433.0%
All	$0.00	Jun 30, 91	N/A

SG&A History

Year	Value	Change
2025	$1.24B	+389.6%
2024	$253.01M	+2.3%
2023	$247.37M	+4.6%
2022	$236.50M	+1.8%
2021	$232.43M	-55.6%
2020	$523.20M	+4.4%
2019	$501.37M	-96.2%
2018	$13.22B	+6.1%
2017	$12.46B	-1.2%
2016	$12.60B	-10.6%
2015	$14.10B	+3.9%
2014	$13.58B	+10.5%
2013	$12.29B	-11.5%
2012	$13.88B	+4.3%
2011	$13.32B	-33.9%
2010	$20.15B	+33.8%
2009	$15.05B	+6.8%
2008	$14.09B	+1.3%
2007	$13.92B	+4.2%
2006	$13.36B	+1.4%

Year	Value	Change
2005	$13.17B	-0.1%
2004	$13.19B	+6.5%
2003	$12.38B	>+9,900.0%
2002	$0.00	0.0%
2001	$0.00	0.0%
2000	$0.00	0.0%
1999	$0.00	-100.0%
1998	$4.45B	+3.2%
1997	$4.32B	+5.0%
1996	$4.11B	-1.8%
1995	$4.19B	+40.7%
1994	$2.98B	>+9,900.0%
1993	$0.00	0.0%
1992	$0.00	0.0%
1991	$0.00	-100.0%
1990	$63.47M	+42.2%
1989	$44.62M	+154.5%
1988	$17.54M	+91.6%
1987	$9.15M	+27.1%
1986	$7.20M	-

FAQ

What is the current annual SG&A of GSK?: As of today, GSK annual SG&A is $1.24B
What is 1-year change in GSK annual SG&A?: GSK annual SG&A is up +389.64% year-over-year
What is 3-year change in GSK annual SG&A?: GSK annual SG&A is up +423.81% over the past 3 years
How far is GSK annual SG&A from its all-time high?: GSK annual SG&A is currently -93.85% below its historical high of $20.15B set on December 31, 2010
How does GSK annual SG&A rank versus sector peers?: GSK annual SG&A is higher than 99.03% of companies in Healthcare sector
When is GSK next annual earnings release?: As of today, the next annual earnings release for GSK has not been scheduled

SG&A Formula

SG&A = Operating Expenses − Cost Of Goods Sold − R&D

Quarterly SG&A

$2.96B$100.52M+3.52%

June 30, 2026

Summary

Current Value: As of today, GSK quarterly SG&A is $2.96B, up +3.52% on June 30, 2026
Historical Performance: GSK quarterly SG&A is up +3.40% year-over-year, up +4.10% over the past 3 years
All-Time High Comparison: GSK quarterly SG&A is currently -57.90% below its historical high of $7.02B set on December 31, 2010
3-Year Low Comparison: GSK quarterly SG&A is +13.38% above its 3-year low of $2.61B reached on March 31, 2025
Sector Comparison: GSK quarterly SG&A is higher than 99.25% of companies in Healthcare sector

Performance

GSK Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly SG&A	Jun 30, 26	$2.96B	+3.5%	+3.4%	+4.1%	+25.1%
Annual SG&A	Dec 31, 25	$1.24B	–	+389.6%	+423.8%	+136.8%
TTM SG&A	Jun 30, 26	$57.71B	+371.4%	+317.7%	+438.4%	+332.9%
Price	Aug 20, 26	$51.96	+2.3%	+29.7%	+50.7%	+21.8%
Quarterly Operating Expenses	Jun 30, 26	$5.25B	+8.9%	+7.0%	+17.5%	+35.5%
Quarterly Operating Profit	Jun 30, 26	$3.22B	+10.9%	+12.3%	+52.4%	+67.3%
Quarterly D&A	Jun 30, 26	$297.10M	-52.4%	-80.5%	-48.2%	-61.1%
Quarterly Revenue	Jun 30, 26	$11.29B	+9.8%	+5.9%	+25.6%	+38.3%

Quarterly SG&A Highs

GSK Quarterly SG&A Highs Comparison
Period	High	Date	Current
1Y	$3.51B	Dec 31, 25	-15.8%
3Y	$4.94B	Sep 30, 24	-40.2%
5Y	$4.94B	Sep 30, 24	-40.2%
All	$7.02B	Dec 31, 10	-57.9%

Quarterly SG&A Lows

GSK Quarterly SG&A Lows Comparison
Period	Low	Date	Current
1Y	$2.86B	Mar 31, 26	+3.5%
3Y	$2.61B	Mar 31, 25	+13.4%
5Y	$2.31B	Sep 30, 21	+27.8%
All	$0.00	Mar 31, 01	N/A

Quarterly SG&A History

Month	Value	Change
Jun 2026	$2.96B	+3.5%
Mar 2026	$2.86B	-18.6%
Dec 2025	$3.51B	+16.2%
Sep 2025	$3.02B	+5.6%
Jun 2025	$2.86B	+9.7%
Mar 2025	$2.61B	-23.6%
Dec 2024	$3.41B	-30.9%
Sep 2024	$4.94B	+58.8%
Jun 2024	$3.11B	+17.5%
Mar 2024	$2.65B	-20.4%
Dec 2023	$3.32B	+14.3%
Sep 2023	$2.91B	+2.3%
Jun 2023	$2.84B	+9.0%
Mar 2023	$2.60B	-8.9%
Dec 2022	$2.86B	+18.3%
Sep 2022	$2.42B	-6.7%
Jun 2022	$2.59B	-32.1%
Mar 2022	$3.81B	+29.0%
Dec 2021	$2.96B	+27.8%
Sep 2021	$2.31B	-2.1%
Jun 2021	$2.36B	-29.4%
Mar 2021	$3.35B	-19.8%
Dec 2020	$4.18B	+21.1%
Sep 2020	$3.45B	+2.5%
Jun 2020	$3.36B	-9.7%
Mar 2020	$3.73B	-15.9%
Dec 2019	$4.43B	+24.3%
Sep 2019	$3.56B	+7.1%
Jun 2019	$3.33B	+3.2%
Mar 2019	$3.23B	-4.3%
Dec 2018	$3.37B	+2.3%
Sep 2018	$3.29B	-1.4%
Jun 2018	$3.34B	+3.9%
Mar 2018	$3.22B	-4.3%
Dec 2017	$3.36B	+11.3%
Sep 2017	$3.02B	-0.9%
Jun 2017	$3.05B	+0.2%
Mar 2017	$3.04B	-9.3%
Dec 2016	$3.35B	+11.4%
Sep 2016	$3.01B	-2.5%
Jun 2016	$3.09B	-0.5%
Mar 2016	$3.10B	-18.2%
Dec 2015	$3.79B	+25.2%
Sep 2015	$3.03B	-22.9%
Jun 2015	$3.93B	+16.8%
Mar 2015	$3.36B	-3.8%
Dec 2014	$3.49B	+4.8%
Sep 2014	$3.33B	-4.1%
Jun 2014	$3.48B	+6.1%
Mar 2014	$3.28B	+28.2%
Dec 2013	$2.55B	-16.9%
Sep 2013	$3.07B	-9.6%
Jun 2013	$3.40B	+5.5%
Mar 2013	$3.23B	-8.4%

Month	Value	Change
Dec 2012	$3.52B	-0.2%
Sep 2012	$3.53B	+1.5%
Jun 2012	$3.48B	+3.4%
Mar 2012	$3.37B	+22.1%
Dec 2011	$2.76B	-14.9%
Sep 2011	$3.24B	-15.3%
Jun 2011	$3.82B	+10.6%
Mar 2011	$3.46B	-50.8%
Dec 2010	$7.02B	+120.7%
Sep 2010	$3.18B	-49.3%
Jun 2010	$6.27B	+72.6%
Mar 2010	$3.64B	-24.7%
Dec 2009	$4.83B	+37.2%
Sep 2009	$3.52B	+1.9%
Jun 2009	$3.45B	+9.5%
Mar 2009	$3.15B	-10.2%
Dec 2008	$3.51B	+3.6%
Sep 2008	$3.39B	-4.8%
Jun 2008	$3.56B	+2.6%
Mar 2008	$3.47B	+0.7%
Dec 2007	$3.45B	+5.5%
Sep 2007	$3.27B	-10.6%
Jun 2007	$3.66B	+11.9%
Mar 2007	$3.27B	>+9,900.0%
Dec 2006	$0.00	0.0%
Sep 2006	$0.00	0.0%
Jun 2006	$0.00	0.0%
Mar 2006	$0.00	0.0%
Dec 2005	$0.00	0.0%
Sep 2005	$0.00	0.0%
Jun 2005	$0.00	0.0%
Mar 2005	$0.00	0.0%
Dec 2004	$0.00	0.0%
Sep 2004	$0.00	0.0%
Jun 2004	$0.00	0.0%
Mar 2004	$0.00	0.0%
Dec 2003	$0.00	0.0%
Sep 2003	$0.00	0.0%
Jun 2003	$0.00	0.0%
Mar 2003	$0.00	0.0%
Dec 2002	$0.00	0.0%
Sep 2002	$0.00	0.0%
Jun 2002	$0.00	0.0%
Mar 2002	$0.00	0.0%
Dec 2001	$0.00	0.0%
Sep 2001	$0.00	0.0%
Jun 2001	$0.00	0.0%
Mar 2001	$0.00	-100.0%
Sep 2000	$2.56B	-7.7%
Jun 2000	$2.77B	+10.6%
Mar 2000	$2.50B	+117.0%
Jun 1999	$1.15B	+5.2%
Jun 1998	$1.10B	-

FAQ

What is the current quarterly SG&A of GSK?: As of today, GSK quarterly SG&A is $2.96B
What is GSK quarterly SG&A most recent change?: GSK quarterly SG&A was up +3.52% on June 30, 2026
What is 1-year change in GSK quarterly SG&A?: GSK quarterly SG&A is up +3.40% year-over-year
How far is GSK quarterly SG&A from its all-time high?: GSK quarterly SG&A is currently -57.90% below its historical high of $7.02B set on December 31, 2010
How does GSK quarterly SG&A rank versus sector peers?: GSK quarterly SG&A is higher than 99.25% of companies in Healthcare sector
When is GSK next earnings release?: The next earnings release for GSK is on October 28, 2026

SG&A Formula

SG&A = Operating Expenses − Cost Of Goods Sold − R&D

TTM SG&A

$57.71B$3.16B+5.79%

June 30, 2026

Summary

Current Value: As of today, GSK TTM SG&A is $57.71B, up +5.79% on June 30, 2026
Historical Performance: GSK TTM SG&A is up +317.68% year-over-year, up +438.40% over the past 3 years
All-Time High Comparison: GSK TTM SG&A is currently -4.43% below its historical high of $60.39B set on an earlier date
3-Year Low Comparison: GSK TTM SG&A is +126.18% above its 3-year low of $25.52B reached on an earlier date
Sector Comparison: GSK TTM SG&A is higher than 97.94% of companies in Healthcare sector

Performance

GSK Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM SG&A	Jun 30, 26	$57.71B	+371.4%	+317.7%	+438.4%	+332.9%
Annual SG&A	Dec 31, 25	$1.24B	–	+389.6%	+423.8%	+136.8%
Quarterly SG&A	Jun 30, 26	$2.96B	+3.5%	+3.4%	+4.1%	+25.1%
Price	Aug 20, 26	$51.96	+2.3%	+29.7%	+50.7%	+21.8%
TTM Operating Profit	Jun 30, 26	$11.14B	+3.3%	+46.4%	+42.4%	+25.5%
TTM D&A	Jun 30, 26	$3.36B	-26.8%	-31.6%	+38.6%	-38.9%
TTM Revenue	Jun 30, 26	$44.55B	+1.4%	+8.8%	+26.3%	+8.4%

TTM SG&A Highs

GSK TTM SG&A Highs Comparison
Period	High	Date	Current
1Y	$57.71B	N/A	at high
3Y	$57.71B	N/A	at high
5Y	$57.71B	N/A	at high
All	$60.39B	N/A	-4.4%

TTM SG&A Lows

GSK TTM SG&A Lows Comparison
Period	Low	Date	Current
1Y	$43.52B	N/A	+32.6%
3Y	$25.52B	N/A	+126.2%
5Y	$25.52B	N/A	+126.2%
All	-$29.95B	N/A	+292.7%

TTM SG&A History

Month	Value	Change
Jun 2026	$12.34B	+0.8%
Mar 2026	$12.24B	+2.1%
Dec 2025	$11.99B	+0.8%
Sep 2025	$11.90B	-13.9%
Jun 2025	$13.82B	-1.8%
Mar 2025	$14.07B	-0.3%
Dec 2024	$14.11B	+0.6%
Sep 2024	$14.02B	+17.0%
Jun 2024	$11.98B	+2.3%
Mar 2024	$11.71B	+0.4%
Dec 2023	$11.67B	+4.1%
Sep 2023	$11.21B	+4.6%
Jun 2023	$10.72B	+2.4%
Mar 2023	$10.47B	-10.4%
Dec 2022	$11.68B	-0.8%
Sep 2022	$11.78B	+0.9%
Jun 2022	$11.67B	+2.0%
Mar 2022	$11.45B	+4.3%
Dec 2021	$10.98B	-10.0%
Sep 2021	$12.20B	-8.5%
Jun 2021	$13.33B	-7.0%
Mar 2021	$14.33B	-2.6%
Dec 2020	$14.71B	-1.7%
Sep 2020	$14.97B	-0.8%
Jun 2020	$15.08B	+0.2%
Mar 2020	$15.05B	+3.4%
Dec 2019	$14.55B	+7.9%
Sep 2019	$13.49B	+2.1%
Jun 2019	$13.22B	-0.1%
Mar 2019	$13.23B	+0.1%
Dec 2018	$13.22B	+0.1%
Sep 2018	$13.21B	+2.1%
Jun 2018	$12.94B	+2.3%
Mar 2018	$12.64B	+1.4%
Dec 2017	$12.46B	+0.1%
Sep 2017	$12.45B	+0.1%
Jun 2017	$12.44B	-0.3%
Mar 2017	$12.48B	-0.5%
Dec 2016	$12.54B	-3.4%
Sep 2016	$12.98B	-0.1%
Jun 2016	$13.00B	-6.1%
Mar 2016	$13.84B	-1.8%
Dec 2015	$14.10B	+2.1%
Sep 2015	$13.81B	-2.2%
Jun 2015	$14.12B	+3.3%
Mar 2015	$13.67B	+0.6%
Dec 2014	$13.58B	+7.4%
Sep 2014	$12.64B	+2.1%
Jun 2014	$12.38B	+0.6%
Mar 2014	$12.31B	+0.4%
Dec 2013	$12.26B	-7.3%
Sep 2013	$13.23B	-3.3%
Jun 2013	$13.68B	-0.6%
Mar 2013	$13.76B	-1.0%

Month	Value	Change
Dec 2012	$13.90B	+5.8%
Sep 2012	$13.13B	+2.3%
Jun 2012	$12.84B	-2.6%
Mar 2012	$13.18B	-0.7%
Dec 2011	$13.27B	-24.3%
Sep 2011	$17.54B	+0.3%
Jun 2011	$17.48B	-12.3%
Mar 2011	$19.93B	-0.9%
Dec 2010	$20.11B	+12.2%
Sep 2010	$17.92B	-1.9%
Jun 2010	$18.26B	+18.3%
Mar 2010	$15.44B	+3.2%
Dec 2009	$14.96B	+9.7%
Sep 2009	$13.64B	+1.0%
Jun 2009	$13.51B	-0.8%
Mar 2009	$13.61B	-2.3%
Dec 2008	$13.93B	+0.5%
Sep 2008	$13.86B	+0.9%
Jun 2008	$13.74B	-0.7%
Mar 2008	$13.84B	+1.5%
Dec 2007	$13.64B	+33.8%
Sep 2007	$10.19B	+47.2%
Jun 2007	$6.93B	+111.9%
Mar 2007	$3.27B	>+9,900.0%
Dec 2006	$0.00	0.0%
Sep 2006	$0.00	0.0%
Jun 2006	$0.00	0.0%
Mar 2006	$0.00	0.0%
Dec 2005	$0.00	0.0%
Sep 2005	$0.00	0.0%
Jun 2005	$0.00	0.0%
Mar 2005	$0.00	0.0%
Dec 2004	$0.00	0.0%
Sep 2004	$0.00	0.0%
Jun 2004	$0.00	0.0%
Mar 2004	$0.00	0.0%
Dec 2003	$0.00	0.0%
Sep 2003	$0.00	0.0%
Jun 2003	$0.00	0.0%
Mar 2003	$0.00	0.0%
Dec 2002	$0.00	0.0%
Sep 2002	$0.00	0.0%
Jun 2002	$0.00	0.0%
Mar 2002	$0.00	0.0%
Dec 2001	$0.00	0.0%
Sep 2001	$0.00	-100.0%
Jun 2001	$2.56B	-52.0%
Mar 2001	$5.33B	-32.0%
Sep 2000	$7.83B	+48.5%
Jun 2000	$5.27B	+44.1%
Mar 2000	$3.66B	+217.0%
Jun 1999	$1.15B	+5.2%
Jun 1998	$1.10B	-

FAQ

What is the current TTM SG&A of GSK?: As of today, GSK TTM SG&A is $57.71B
What is GSK TTM SG&A most recent change?: GSK TTM SG&A was up +5.79% on June 30, 2026
What is 1-year change in GSK TTM SG&A?: GSK TTM SG&A is up +317.68% year-over-year
How does GSK TTM SG&A rank versus sector peers?: GSK TTM SG&A is higher than 97.94% of companies in Healthcare sector
When is GSK next earnings release?: The next earnings release for GSK is on October 28, 2026

SG&A Formula

SG&A = Operating Expenses − Cost Of Goods Sold − R&D

Data Sources & References

GSK Official Website www.gsk.com
GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk